| Owais Rahim, MD | |
|
545 Rugh St, Greensburg, PA 15601-5636 | |
| (724) 836-5500 | |
| (724) 836-8471 |
| Full Name | Owais Rahim |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 35 Years |
| Location | 545 Rugh St, Greensburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780790626 | NPI | - | NPPES |
| 0019038200001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD067007L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Excela Health Westmoreland Regional Hospital | Greensburg, PA | Hospital |
| Excela Health Latrobe Hospital | Latrobe, PA | Hospital |
| Excela Health - Frick Hospital | Mount pleasant, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Excela Health Physician Practices, Inc | 6204737117 | 438 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
Medco Health Solutions, Inc. today reported second-quarter 2011 GAAP diluted EPS of $0.85, up 10.4 percent compared to $0.77 for the second quarter of 2010. Adjusting for all amortization of intangible assets, second-quarter 2011 diluted earnings per share increased 10.3 percent to $0.96, up from $0.87 in the second quarter of 2010.
The time to maximal sugar level during an oral glucose tolerance test is associated with higher risk for prediabetes and could give important information about the ability of the pancreas to secrete insulin, according to research presented at the Endocrine Society's 99th annual meeting, ENDO 2017, in Orlando, Fla.
According to new research from the U.S., using cocaine can cause chest pain and other symptoms similar to a heart attack.
The world's first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa, WHO confirmed today. Funding is now secured for the initial phase of the programme and vaccinations are due to begin in 2018.
› Verified 1 days ago
| Entity Name | Excela Health Physician Practices, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821225202 PECOS PAC ID: 6204737117 Enrollment ID: O20040322001393 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
Medco Health Solutions, Inc. today reported second-quarter 2011 GAAP diluted EPS of $0.85, up 10.4 percent compared to $0.77 for the second quarter of 2010. Adjusting for all amortization of intangible assets, second-quarter 2011 diluted earnings per share increased 10.3 percent to $0.96, up from $0.87 in the second quarter of 2010.
The time to maximal sugar level during an oral glucose tolerance test is associated with higher risk for prediabetes and could give important information about the ability of the pancreas to secrete insulin, according to research presented at the Endocrine Society's 99th annual meeting, ENDO 2017, in Orlando, Fla.
According to new research from the U.S., using cocaine can cause chest pain and other symptoms similar to a heart attack.
The world's first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa, WHO confirmed today. Funding is now secured for the initial phase of the programme and vaccinations are due to begin in 2018.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Owais Rahim, MD 520 Jefferson Ave, Jeannette, PA 15644-2538 Ph: (724) 527-8060 | Owais Rahim, MD 545 Rugh St, Greensburg, PA 15601-5636 Ph: (724) 836-5500 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
Medco Health Solutions, Inc. today reported second-quarter 2011 GAAP diluted EPS of $0.85, up 10.4 percent compared to $0.77 for the second quarter of 2010. Adjusting for all amortization of intangible assets, second-quarter 2011 diluted earnings per share increased 10.3 percent to $0.96, up from $0.87 in the second quarter of 2010.
The time to maximal sugar level during an oral glucose tolerance test is associated with higher risk for prediabetes and could give important information about the ability of the pancreas to secrete insulin, according to research presented at the Endocrine Society's 99th annual meeting, ENDO 2017, in Orlando, Fla.
According to new research from the U.S., using cocaine can cause chest pain and other symptoms similar to a heart attack.
The world's first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa, WHO confirmed today. Funding is now secured for the initial phase of the programme and vaccinations are due to begin in 2018.
› Verified 1 days ago
Nawaf I Nseir, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 562 Shearer St Ste B104, Greensburg, PA 15601 Phone: 724-836-8303 Fax: 724-836-8311 | |
Thomas George Tomci, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 539 Green St, Greensburg, PA 15601 Phone: 724-834-1122 Fax: 724-838-8112 | |
John Morcos, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 400 Oakbrook Dr, Suite 2201, Greensburg, PA 15601 Phone: 724-834-1463 | |
James E Adisey, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 530 South St, Second Floor, Greensburg, PA 15601 Phone: 724-689-1358 Fax: 724-689-0547 | |
Robert Gordon Tymoczko, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 545 Rugh St., Greensburg, PA 15601 Phone: 724-836-8400 | |
Gautam Agrawal, M.D , M.P.H Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 562 Shearer St Ste B104, Greensburg, PA 15601 Phone: 724-836-8303 Fax: 724-836-8311 | |
Matthew G Sulecki, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 200 Village Dr, Greensburg, PA 15601 Phone: 724-838-1900 Fax: 724-838-5620 |